The Smarter Approach to Pet Health
PetIQ is redefining pet health by giving pet parents a smarter way to take care of their pets and creating exceptional value for retailers, manufacturers and shareholders.
Convenient & Affordable Preventive Veterinary Services
As a leading solutions provider in the rapidly expanding veterinary services category, PetIQ is breaking down barriers to make it easier for pet owners to care for their pets.
Industry-Leading Pet Health Product Brands
Our industry-leading pet health products and brands deliver prescription medication, over-the-counter treatments, and treats to leading retailers across the country.
Best-in-Class Manufacturing & Distribution Capabilities
Our vertical integrated core business segments demand a robust commitment to research, product development, manufacturing, packaging, and distribution.
Join Us! We’re Seeking Talented Individuals Who Love Pets as Much as We Do
We couldn’t do what we do without great people who have a passion for pets. We are an innovative, team-oriented and growing company dedicated to helping pets live their best lives.
May 9, 2023
PetIQ, Inc. Reports First Quarter 2023 Financial Results
The Company’s acquisition of Rocco and Roxie that closed in the quarter provides us with a portfolio that allows us to expand into the pet stain and odor category…
PetIQ Reports 4th Quarter & Full Year 2022 Financial Results
We are pleased to report net sales and adjusted EBITDA in-line with our 2022 full year guidance as well as record annual cash generation. PetIQ captured a disproportionate amount of market share and outperformed the broader pet product categories in which we compete.
Looking forward, we believe we are well positioned for solid growth in 2023 across our Product and Services segments…
PetIQ, Inc. Announces $30 Million Stock Repurchase Program
PetIQ, Inc. (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that as part of the Company’s long-term strategy to maximize stockholder value, its Board of Directors has authorized a stock repurchase program, which will enable the Company to repurchase up to $30 million in aggregate of the Company’s outstanding shares of common stock.